Medication info
Metmaril Tablet 2/500 mg

Metmaril Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
[Domestic] White oblong film-coated tablets [Export] White oblong film-coated tablets, imprinted with JI on one side and 2|50 on the other side.
Packaging
30 tablets/box (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201107510 · Approved 2011.09.29 · Insurance code 645403590

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes achieve more effective blood sugar control in conjunction with diet and exercise. The combination of glymepiride and metformin helps manage blood sugar levels consistently. Therefore, this medication is used for the improvement of blood sugar control in type 2 diabetes.

How to take

Adult dose

Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, requiring extreme caution. Particularly, if kidney function declines rapidly, the drug may accumulate in the body, increasing the risk of lactic acidosis. If there are signs of dehydration, severe diarrhea, vomiting, or fever, temporary discontinuation of the medication and consultation with a doctor is necessary. It is safest to avoid this medication in patients with certain low kidney functions, severe liver dysfunction, pregnant women, or breastfeeding women. Additionally, it should be avoided in cases of acute metabolic acidosis, serious infections, or pre- and post-operative conditions. Patients at high risk of hypoglycemia, such as those with poor nutritional status, irregular meals, elderly individuals, or those with severely decreased liver function require closer monitoring during dosing. Close monitoring for hypoglycemic symptoms is especially important during the initial stages of treatment. During the use of this medication, gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) are common but generally temporary. If symptoms are severe or persistent, consult a doctor. Rarely, allergic reactions, blood abnormalities, or vitamin B12 deficiency can occur, thus requiring regular testing and monitoring. This medication may interact with other drugs; therefore, if other medications are being taken, patients must inform their doctor. Caution is particularly needed when used in combination with drugs that can affect kidney function or blood sugar levels. Pregnant women or those planning to become pregnant are recommended to switch to insulin therapy instead of this medication. In breastfeeding cases, the drug may pass into breast milk, so administration should be avoided. Safety in children and adolescents has not been sufficiently established, hence it should be administered cautiously in pediatric patients. Elderly patients often experience decreased kidney function, thus necessitating dosage adjustments and regular kidney function tests. In cases of overdose, hypoglycemia or severe metabolic disturbances may occur, necessitating immediate medical intervention and possibly emergency treatment such as dialysis. Patients should maintain regular meals and exercise while consistently monitoring blood sugar and kidney function to achieve optimal blood sugar management. Additionally, in stressful situations such as acute illness or surgery, temporary conversion to insulin therapy may be considered. Caution is needed when driving or operating machinery as hypoglycemia or agility impairments may occur. Keep out of reach of children; avoid transferring to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, indigestion, constipation, abdominal pain, metallic taste, visual impairment, taste disorders, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, neutropenia, agranulocytosis, pancytopenia, decreased vitamin B12, peripheral neuropathy, increased liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity reactions, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, abdominal pain, abdominal distension, vomiting, indigestion, palpitations, dizziness, diarrhea, nausea, leg edema, cardiac arrest, rectal carcinoma, hypoglycemia, dizziness, liver dysfunction, arthralgia, facial edema, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air or moisture ingress. Furthermore, avoid hot or excessively cold places, keeping it at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

[Domestic] White oblong film-coated tablets [Export] White oblong film-coated tablets, imprinted with JI on one side and 2|50 on the other side.

Package unit

30 tablets/box (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.